Statistics

I consent to completing the survey as described above

Which best describes your current role?

Which best describes your primary practice setting?

How many years have you been practicing oncology?

In which US State is your primary practice located?

Approximately how many active breast cancer patients (early and metastatic) do you personally manage per month?

Are you currently involved in clinical research (e.g., serving as a principal investigator, sub-investigator, or enrolling patients into trials)?

Which of the following sources do you regularly use to stay up to date on new clinical data in oncology? Select all that apply.

You mentioned you use peer-reviewed journals for clinical updates. Which peer-reviewed journals do you use most often to stay up to date? Select all that apply.

You mentioned you use medical news websites for clinical updates. Which medical news websites do you use most often? Select all that apply.

You mentioned you use social or professional platforms for clinical updates. Which social or professional platforms do you use most often for clinical updates? Select all that apply.

You mentioned you use medical news and/or professional platforms for clinical updates. When you use medical news or professional platforms, what do you mainly use them for? Select all that apply.

You mentioned you use clinical guideline websites. Which professional societies or guideline bodies do you rely on most for clinical guidance in breast cancer? Select all that apply.

You mentioned you use podcasts for clinical updates. Which oncology podcasts do you listen to most often for clinical updates? Select all that apply.

When new clinical data is relevant to your practice, which formats do you typically prioritize first to review the information? Please select your top three points of engagement.

When attending a major scientific congress, which information formats do you find most useful before the congress? Please select up to two.

When attending a major scientific congress, which types of sessions or activities do you prioritize during the congress? Please select up to two.

When attending a major scientific congress, which information formats do you find most useful after the congress? Please select up to two.

In which situations do you find 1:1 scientific discussions with pharmaceutical medical representatives (Medical Science Liaisons) most valuable? Select up to two.

How do you prefer to engage in 1:1 scientific discussions with pharmaceutical representatives?

When interpreting scientific or clinical evidence and making treatment decisions, how important are peer perspectives to you?

At which points, if any, are peer perspectives most valuable to you? Select up to two most valuable situations.

Which types of peer perspectives do you find most useful when interpreting new scientific data relevant to your clinical practice? Select up to two most useful types of peer perspectives.

When interpreting new clinical data in breast cancer, are there specific individuals whose perspectives you actively seek out?